TABLE 1.
Biomarker | Predictive/prognostic | Target | Evidence |
---|---|---|---|
BCAR4 amplification | Predictive | HER2 | Low |
KRAS mutation | Prognostic | KRAS | Strong |
HER2 amplification | Predictive/prognostic | HER2 | Moderate |
HER2 mutation | Predictive | HER2 | Strong |
PDL-1 expression | Predictive/prognostic | Immune checkpoint inhibition | Moderate |